30
Views
21
CrossRef citations to date
0
Altmetric
Original

L1, a major granulocyte protein; isolation of high quantities of its subunits

&
Pages 769-774 | Received 22 Dec 1989, Accepted 23 Mar 1990, Published online: 29 Mar 2011

References

  • Fagerhol M K, Dale I, Andersson T. Release and quantitation of a leucocyte-derived protein (LI). Scand J Haematol 1980; 24: 393–8
  • Fagerhol M K, Andersson K B, Naess-Andresen C-F, Brandtzaeg P, Dale I. Calprotectin (the LI leukocyte protein). Stimulus-Response Coupling. The Role of Intracellular Calcium, V L Smith, J R Dedman. The Telford Press, Caldwell, NJ 1990; 189–212
  • Dale I, Brandtzaeg P, Fagerhol M K, Scott H. Distribution of a new myelomonocytic antigen (LI) in human peripheral blood leukocytes: immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985; 84: 24–34
  • Gabrielsen T-Ø, Dale I, Brandtzaeg P, Hoel P S, Fagerhol M K, Larsen T E, Thune P O. Epidermal and dermal distribution of a myelomonocytic antigen (LI) shared by epithelial cells in various inflammatory skin diseases. J Am Acad Dermatol 1986; 15: 173–9
  • Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalin-resistant myelomonocytic antigen (LI) in human tissues. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol 1987; 87: 700–7
  • Gabrielsen T O, Brandtzaeg P, Hoel P S, Dale I. Epithelial distribution of a myelomonocytic antigen LI in relation to cutaneous malignancies and melanocytic naevi. Br J Dermatol 1988; 118: 59–67
  • Dale I, Brandtzaeg P. Expression of the epithelial LI antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histo-pathology 1989; 14: 493–502
  • Andersson K B, Sletten K, Berntzen H B, Dale I, Brandtzaeg P, Jellum E, Fagerhol M K. The leucocyte LI protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988; 28: 241–5
  • Berntzen H B, Fagerhol M K. LI, a major granulocyte protein: antigenic properties of its subunits. Scand J Clin Lab Invest 1988; 48: 647–52
  • Odink K, Cerletti N, Bruggen J, Clerc R G, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987; 330: 80–2
  • Dorin J R, Novak M, Hill R E, Brock D JH, Secher D S, van Heyningen V. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature 1987; 326: 614–7
  • Wilkinson M M, Busuttil A, Hayward C, Brock D JH, Dorin J R, van Heyningen V. Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J Cell Sci 1988; 91: 221–30
  • Kelly S E, Jones D B, Fleming S. Calgranulin expression in inflammatory dermatoses. J Pathol 1989; 159: 17–21
  • Fagerhol M K, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Europ Physiopath Resp 1980; 16((Suppl.))273–81
  • Dale I, Fagerhol M K, Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the LI antigen. Eur J Biochem 1983; 134: 1–6
  • Sander J, Fagerhol M K, Bakken J S, Dale I. Plasma levels of the leucocyte LI protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357–62
  • Holt J, Fagerhol M K, Dale I. Quantitation of a leukocyte protein (LI) in urine. Acta Pa;diatr Scand 1983; 72: 615–6
  • Munthe E, Fagerhol M, Jellum E, Rico P. The leukocyte LI protein. A new and better marker of disease activity in rheumatoid arthritis. Abstr XVI Int Congress Rheumatol. Sydney 1985, Abstr 124
  • Berntzen H B, Munthe E, Fagerhol M K. The major leukocyte protein LI as an indicator of inflammatory joint disease. Scand J Rheumatol 1988, Suppl. 76: 251–6
  • Berntzen H B, Munthe E, Fagerhol M K. A longitudinal study of the leukocyte protein LI as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989; 16: 1416–20
  • Brandtzaeg P, Dale I, Fagerhol M K. Distribution of a formalin-resistant myelomonocytic antigen (LI) in human tissues. Comparison with other leukocyte markers by paired immunofluorescence and immunoenzyme staining. Am J Clin Pathol 1987; 87: 681–99
  • Berntzen H B, Willard-Gallo K E, Munthe E, Jellum E. Analysis of cellular and membrane extracts of human leukocytes from rheumatoid arthritis patients using two-dimensional electrophoresis. Scand J Clin Lab Invest 1986; 46((Suppl. 184))77–83
  • Anderson N G, Anderson N L. Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: multiple isoelectric focusing. Anal Biochem 1978; 85: 331–40
  • Anderson N L, Hickman B J. Analytical techniques for cell fractions. XXIV. Isoelectric point standards for two-dimensional electrophoresis. Anal Biochem 1979; 93: 312–20
  • Anderson N L, Anderson N G. Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. Anal Biochem 1978; 85: 341–54
  • Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 1985; 6: 103–12
  • Daufeldt J A, Harrison H H. Quality control and technical outcome of ISO-DALT two-dimensional electrophoresis in a clinical laboratory setting. Clin Chem 1984; 30(12)1972–80
  • Lagasse E, Clerc R G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol 1988; 8: 2402–10

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.